Stay updated on Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T20:52:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer's revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T20:56:57.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, indicating the record is inaccessible; this reflects a site-access issue rather than a change to trial details.
    Difference
    19%
    Check dated 2026-09-20T19:55:50.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The NIH grant/contract tag was added to the list of Other Study ID Numbers, and the page revision label was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T15:30:11.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    A new page revision tag, Revision: v3.6.5, was added. The Investigator Inquiry Form and the previous revision tag Revision: v3.6.4 were removed, reflecting changes to the page's inquiry options and version history.
    Difference
    0.1%
    Check dated 2026-08-08T23:32:21.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Revision tag on the page was updated from v3.6.3 to v3.6.4, indicating a backend update to the Study Details page. This update does not modify the study data visible to users.
    Difference
    0.0%
    Check dated 2026-07-25T16:48:24.000Z thumbnail image

Stay in the know with updates to Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.